Clinical efficacy and safety: radiopharmaceuticals and diagnostic agents
The European Medicines Agency's scientific guidelines on radiopharmaceuticals and diagnostic agents help medicine developers prepare marketing authorisation applications for human medicines.
If you have comments on a document which is open for consultation, use the form for submission of comments on scientific guidelines .
Please submit your comments to the following email address: firstname.lastname@example.org.
For a complete list of scientific guidelines currently open for consultation, see Public consultations.
More information is available on the activities of the CHMP's Radiopharmaceuticals Drafting Group.